Sunmin Park, M.D., Ph.D.
Leukemia
Assistant Professor, Division of Leukemia, Department of Hematology and Hematopoietic Cell Transplantation
Sunmin Park, M.D., Ph.D., is a hematologist-oncologist at City of Hope® Cancer Center Duarte, where she specializes in treating leukemia. Dr. Park works closely with each patient’s multidisciplinary care team to provide compassionate, evidence-based care that incorporates the latest in innovative immunology and cellular therapies, with the goal of helping patients navigate their illness and receive outstanding care.
Drawn to City of Hope by its commitment to leading-edge stem cell and immunology treatments, Dr. Park is a physician-scholar with multiple peer-reviewed publications. Her current research agenda includes work focusing on topics such as the use of biomarkers to predict patient outcomes and approaches to graft-versus-host disease.
After earning her medical degree and Ph.D. in the combined Medical Scientist Training Program at the Washington University School of Medicine in St. Louis, Missouri, Dr. Park completed her internal medicine internship and residency at the University of Pittsburgh Medical Center in Pennsylvania, followed by fellowships in hematology-oncology at the University of California, Los Angeles, and hematopoietic stem cell transplantation at City of Hope.
Location
Duarte Cancer Center
Duarte, CA 91010
Education & Experience
Degrees
- 2017, Doctor of Medicine, Doctor of Philosophy, Medical Scientist Training Program (MSTP; MD-Ph.D Combined Doctoral Program), Washington University School of Medicine, Saint Louis, MO
- 2008, Master of Science, Chemistry, University of Pennsylvania, Philadelphia, PA
- 2008, Bachelor of Arts, Biochemistry, University of Pennsylvania, Philadelphia, PA
Residency
2017–2020, Internal Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA
Fellowships
- 2024–2025, Hematopoietic Cell Transplantation, City of Hope, Duarte, CA
- 2021–2024, Hematology-Oncology, University of California, Los Angeles
Professional Experience
- 2025–present, Assistant Professor, Division of Leukemia, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA
- 2020–2021, Clinical Assistant Professor of Medicine (Clinical Educator), University of Southern California, Los Angeles, CA
Awards & Memberships
2016, John Atkinson Fellowship Washington University in St Louis, School of Medicine,
Department of Immunology and Pathology
- 2008, John C. Makris Memorial Award, Biochemistry Program, University of Pennsylvania
- 2007, Phi Beta Kappa, University of Pennsylvania Chapter
2004–2008, Participant, Roy Vagelos Scholar Program in Molecular Life Sciences
University of Pennsylvania
Publications
- Choi J, Park S, Biering SB, Selleck E, Liu CY, Zhang X, Fujita N, Saitoh T, Akira S, Yoshimori T, Sibley LD, Hwang S, Virgin VW. The parasitophorous vacuole membrane of Toxoplasma gondii is targeted for disruption by ubiquitin-like conjugation systems of autophagy. Immunity, 2014 Jun 19;40(6):924-35. PMID 24931121
- Kimmey JM, Huynh JP, Weiss LA, Park S, Kambal A, Debnath J, Virgin HW, Stallings CL. Unique role for ATG5 in neutrophil-mediated immunopathology during Mycobacterium tuberculosis infection. Nature 2015 Dec 24;528(7583):565-9 PMID 26649827
- Park S, Buck MD, Desai C, Zhang X, Loginicheva E, Martinez J, Freeman ML, Saitoh T, Akira S, Guan JL, He YW, Blackman MA, Handley SA, Levine B, Green DR, Reese TA, Artyomov MN, Virgin HW. Autophagy genes enhance murine gammaherpesvirus 68 reactivation from latency by preventing virus-induced systemic inflammation. Cell Host Microbe 2016 Jan 13;19(1):91-101 PMID 26764599
- Redmann V, Lamb CA, Hwang S, Orchard RC, Kim S, Razi M, Milam A, Park S, Yokoyama CC, Kambal A, Kreamalmeyer D, Bosch MK, Xiao M, Green K, Kim J, Pruett-Miller SM, Ornitz DM, Allen PM, Beatty WL, Schmidt RE, DiAntonio A, Tooze SA, Virgin HW. Clec16a is critical for autolysosome function and purkinje cell survival. Sci Rep. 2016 Mar 18;6:23325 PMID 26987296
- Santeford A, Wiley LA, Park S, Bamba S, Nakamura R, Gdoura A, Ferguson T, Guan JL, Saitoh T, Akira S, Xaiver RJ, Virgin HW, Apte RS. Impaired autophagy in macrophages promotes inflammatory eye disease. Autophagy 2016 July 27:0 PMID 27463423
- Yokoyama CC, Baldridge MT, Leung DW, Zhao G, Desai C, Liu TC, Diaz-Ochoa VE, Huynh JP, Kimmey JM, Sennott EL, Hole CR, Idol RA, Park S, Storek KM, Wang C, Hwang S, Viehmann Milam A, Chen E, Kerinnes T, Starnbach MN, Handley SA, Mysorekar IU, Allen PM, Monack DM, Dinauer MC, Doering TL, Tsolis RM, Dworkin JE, Stallings CL, Amarsinghe GK, Micchelli CA, Virgin HW. LysMD3 is a type II membrane protein without an in vivo role in the response to a range of pathogens. J Biol Chem 2018 Apr 20; 293 (16): 6022-6038. PMID 29496999
- Wang YT, Zaitsev K, Lu Q, Li S, Schaiff WT, Kim KW, Droit L, Wilen CB, Desai C, Balce DR, Orchard RC, Orvedahl A, Park S, Kreamalmeyer D, Handley SA, Pfeifer JD, Baldridge MT, Artyomov MN, Stallings CL, Virgin HW. Select autophagy genes maintain quiescence of tissue- resident macrophages and increase susceptibility to Listeria monocytogenes. Nature Microbiol. 2020 Feb;5(2): 272-281. PMID 31959973
- Oliai C, Park S, Damon LE, Jonas BA, Jeyakumar D, Wieduwilt MJ, Logan AC, Callas B, Hannigan CA, Gaut DL, Schiller GJ. CPX-351 plus Gemtuzumab Ozogamicin for Relapse/Refractory Acute Myelogenous Leukemia: A University of California Hematologic Malignancies Consortium Trial. Leukemia & Lymphoma 2024 Dec 17:1-7. PMID 39689718